The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Unknown
148 enrolled
ARTIHCC
Unknown
535 enrolled
Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids
Unknown
3,200 enrolled
Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
Unknown
96 enrolled
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
Unknown
46 enrolled
Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum
Unknown
200 enrolled
Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence
Unknown
300 enrolled
The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
Unknown
30 enrolled
T1 Squamous Cell Carcinomas of the Lip
Unknown
300 enrolled
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Unknown
965 enrolled
Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis
Unknown
800 enrolled
REDUCE
Unknown
220 enrolled
CORE1
Unknown
2,000 enrolled
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Unknown
100 enrolled
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Unknown
150 enrolled
Bio-NMDAr
Unknown
400 enrolled
myCare-102
Unknown
730 enrolled
How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas
Unknown
100 enrolled
Lenvatinib Therapy in HCC Patients After LDLT
Unknown
30 enrolled
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Unknown
160 enrolled
Breast Cancer Liquid Biopsy Trial
Unknown
450 enrolled
STARR
Unknown
90 enrolled
Pituitary Adenoma and Serum Lipid
Unknown
1,000 enrolled
The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression
Unknown
500 enrolled
Prognosis of Low-grade Endometrial Stromal Sarcoma
Unknown
1,000 enrolled
Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter Trial
Unknown
80 enrolled
Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer
Unknown
300 enrolled
e-PPGL
Unknown
139 enrolled
IMMUCOL
Unknown
459 enrolled
RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer
Unknown
500 enrolled
Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy
Unknown
30 enrolled
Postoperative VEGF and Recurrence After Colon Cancer Surgery
Unknown
280 enrolled
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
Unknown
82 enrolled
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
Unknown
300 enrolled
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Unknown
1,354 enrolled
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation
Unknown
139 enrolled
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs
Unknown
320 enrolled
Outcome Analysis of Aspirin in Liver Transplantation
Unknown
3,000 enrolled
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.
Unknown
25 enrolled
CHRU-WCMC
Unknown
84 enrolled
Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin
Unknown
70 enrolled
A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR
Unknown
500 enrolled
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
Unknown
200 enrolled
Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Unknown
100 enrolled
Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk
Unknown
65 enrolled
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
Unknown
50 enrolled
Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Unknown
3,000 enrolled
The Relationship Between Postoperative Changes of Oral and Intestinal Flora and Prognosis
Unknown
100 enrolled
The Biomarker Analysis in Locally Advanced Cervical Cancer
Unknown
62 enrolled
NGSAML
Unknown
40 enrolled